Fake OTCs becoming more common, says ex-DOJ prosecutor
The counterfeiting of over-the-counter drugs is a growing problem according to an ex-criminal prosecutor, but the nature of such medicines means the problem often goes unreported.
The counterfeiting of over-the-counter drugs is a growing problem according to an ex-criminal prosecutor, but the nature of such medicines means the problem often goes unreported.
Onyx Scientific, a UK contract development and manufacturing organisation (CDMO) has completed an API (active pharmaceutical ingredient) production deal for Neuronascent, a US company developing neurological therapies.
Chinese CRO Tigermed has entered a definitive agreement to acquire a majority stake in the ownership of CRO Frontage Laboratories for $50.25m in cash, some of which the company will use to expand clinical capacity in New Jersey.